Tigatuzumab
Product Specifications
CAS Number
918127-53-4
Target
Apoptosis, TNF
Related Pathways
Apoptosis
Purity
0.989
Bioactivity
Tigatuzumab (CS-1008), a humanized monoclonal antibody targeting death receptor 5 (DR5), is a TRAIL-R2 agonist with antitumor activity that induces apoptosis in cancer cells, and can be used to study pancreatic cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog